PHOSOLAMBAN AND CAM KINASE II IN STOMACH SMOOTH MUSCLE PLASTICITY
福索兰班和 CAM 激酶 II 在胃平滑肌可塑性中的作用
基本信息
- 批准号:8168459
- 负责人:
- 金额:$ 21.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-08-01 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAgonistBiological AssayCell VolumesCharacteristicsColonComputer Retrieval of Information on Scientific Projects DatabaseContractile ProteinsDefectDiseaseExhibitsFractionationFrequenciesFundingFundusGastrointestinal tract structureGenetic TranscriptionGrantHoloenzymesHypertrophyImageIn Situ HybridizationInstitutionLeadMapsMechanicsMolecularMuscle ContractionNuclear Localization SignalObstructionPathologyPatternPhosphopeptidesPhosphorylationPhosphotransferasesPhysiologicalPhysiologyPropertyProteomicsRNA SplicingRegulationResearchResearch PersonnelResourcesRoleSerum Response FactorSmooth MuscleSourceStomachTherapeuticTissuesTranslatingUnited States National Institutes of HealthVariantWestern Blottingcalmodulin-dependent protein kinase IIcell motilitygastrointestinalmotility disordermuscle hypertrophyratiometricresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Gastrointestinal smooth muscles adapt contractile activities in response to continuously changing conditions.
Mechanical plasticity, such as hypertrophy, alters the functional capacity of smooth muscles in response to
changing demands by reorganizing contractile bundles. The amplitude and frequency of cytosolic Ca 2+
oscillations encodes information that is translated into physiological responses. CaM kinase II has the
structural, catalytic, and regulatory properties required of a molecular decoder of Ca 2+ oscillations. Fundus
and colon smooth muscles, which exhibit distinct Ca 2+oscillations, express CaM kinase II holoenzymes with
tissue-specific enzymatic properties. In situ hybridization, kinase assays, Western blotting, and ratiometric
Ca 2+ imaging will be used to investigate how CaM kinase II responds to cytosolic Ca 2+ transients in order to
understand how it modulates smooth muscle contractile activity. Hypertrophy of gastrointestinal smooth
muscles due to obstructions of the digestive tract resulting from congenital or acquired defects is associated
with pathologies that lead to several motility disorders. Part of the cell volume increase results from elevated
transcription and expression of contractile proteins under the control of serum response factor. Serum
response factor is activated by CaM kinase II phosphorylation. Fundus and colon smooth muscles express
CaM kinase II splice variants containing a nuclear localization signal. Cellular fractionation, Western blotting,
kinase assays, Q-PCR, phosphopeptide mapping, and expression proteomics will be used to elucidate the
role of CaM kinase II in the activation of contractile protein gene transcription by serum response factor.
Gastrointestinal smooth muscle hypertrophy is important in normal physiology and disease. This project will
explore the regulation and physiological roles of CaM kinase II in normal agonist-stimulated, and abnormal
hypertrophied gastrointestinal smooth muscles. Determining the enzymatic characteristics of gastrointestinal
smooth muscle CaM kinase II and investigating the modulation of gastrointestinal smooth muscle contraction
by CaM kinase II will provide additional information for developing better therapeutics aimed at treating the
myogenic component of the altered motility patterns that underlie digestive tract motility disorders.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
胃肠平滑肌适应收缩活动,以应对不断变化的条件。
机械可塑性,如肥大,改变平滑肌的功能能力,以响应
通过重组收缩束来改变需求。胞浆Ca ~(2+)的振幅和频率
振荡将信息编码成生理反应。CaM激酶II具有
结构,催化和调节性能所需的分子解码器的钙2+振荡。眼底
和结肠平滑肌,表现出明显的钙振荡,表达钙调蛋白激酶II全酶,
组织特异性酶特性。原位杂交、激酶测定、蛋白质印迹和比率测定
钙离子成像将用于研究钙调素激酶II如何响应胞浆钙离子瞬变,以
了解它如何调节平滑肌收缩活动。胃肠平滑肌肥大
由于先天性或后天性缺陷导致的消化道阻塞导致的肌肉
导致几种运动障碍的病理。细胞体积增加的部分原因是
收缩蛋白的转录和表达受血清反应因子的控制。血清
反应因子被CaM激酶II磷酸化激活。胃底和结肠平滑肌表达
含有核定位信号的CaM激酶II剪接变体。细胞分级分离,蛋白质印迹,
激酶测定、Q-PCR、磷酸肽图谱和表达蛋白质组学将用于阐明
CaM激酶II在血清反应因子激活收缩蛋白基因转录中的作用
胃肠平滑肌肥大在正常生理和疾病中是重要的。该项目将
探讨钙调素激酶II在正常激动剂刺激和异常激动剂刺激中的调节和生理作用。
肥大的胃肠平滑肌。测定胃肠道的酶特性
平滑肌钙调素激酶II和研究胃肠平滑肌收缩的调节
将为开发更好的治疗方法提供额外的信息,
肌原性成分的改变运动模式的基础消化道运动障碍。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian A Perrino其他文献
Brian A Perrino的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian A Perrino', 18)}}的其他基金
PHOSOLAMBAN AND CAM KINASE II IN STOMACH SMOOTH MUSCLE PLASTICITY
福索兰班和 CAM 激酶 II 在胃平滑肌可塑性中的作用
- 批准号:
8360517 - 财政年份:2011
- 资助金额:
$ 21.07万 - 项目类别:
COBRE: UNV MED SCH: P2: CAM KINASE II IN SMOOTH MUSCLE PLASTICITY
COBRE:UNV MED SCH:P2:平滑肌可塑性中的 CAM 激酶 II
- 批准号:
7960565 - 财政年份:2009
- 资助金额:
$ 21.07万 - 项目类别:
COBRE: UNV MED SCH: P2: CAM KINASE II IN SMOOTH MUSCLE PLASTICITY
COBRE:UNV MED SCH:P2:平滑肌可塑性中的 CAM 激酶 II
- 批准号:
7610550 - 财政年份:2007
- 资助金额:
$ 21.07万 - 项目类别:
COBRE: UNV MED SCH: P2: CAM KINASE II IN SMOOTH MUSCLE PLASTICITY
COBRE:UNV MED SCH:P2:平滑肌可塑性中的 CAM 激酶 II
- 批准号:
7382017 - 财政年份:2006
- 资助金额:
$ 21.07万 - 项目类别:
COBRE: UNV MED SCH: P2: CAM KINASE II IN SMOOTH MUSCLE PLASTICITY
COBRE:UNV MED SCH:P2:平滑肌可塑性中的 CAM 激酶 II
- 批准号:
7171246 - 财政年份:2005
- 资助金额:
$ 21.07万 - 项目类别:
PROTEIN KINASE II IN SMOOTH MUSCLE PLASTICITY
蛋白质激酶 II 在平滑肌可塑性中的作用
- 批准号:
6981912 - 财政年份:2004
- 资助金额:
$ 21.07万 - 项目类别:
GASTROINTESTINAL CALMODULIN-DEPENDENT PROTEIN KINASE II
胃肠道钙调蛋白依赖性蛋白激酶 II
- 批准号:
6402598 - 财政年份:2000
- 资助金额:
$ 21.07万 - 项目类别:
GASTROINTESTINAL CALMODULIN-DEPENDENT PROTEIN KINASE II
胃肠道钙调蛋白依赖性蛋白激酶 II
- 批准号:
6190728 - 财政年份:2000
- 资助金额:
$ 21.07万 - 项目类别:
CALCINEURIN REGULATION BY MEMBRANE PHOSPHOLIPIDS
膜磷脂对钙调磷酸酶的调节
- 批准号:
2039036 - 财政年份:1997
- 资助金额:
$ 21.07万 - 项目类别:
CALCINEURIN REGULATION BY MEMBRANE PHOSPHOLIPIDS
膜磷脂对钙调磷酸酶的调节
- 批准号:
6187982 - 财政年份:1997
- 资助金额:
$ 21.07万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 21.07万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 21.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 21.07万 - 项目类别: